Sign in
4/A

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0001725092-26-000009

Options or other derivatives

  • Chief Executive Officer acquired 136,359 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lin Shao-Lee · Chief Executive Officer

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-01 Grant or award : show line 1 in the form Pre-Funded Warrants (Right to Buy) +90,906 $11.00 $999,966 90,906 I
2026-06-01 Grant or award : show line 2 in the form Common Stock Warrants (Right to Buy) +45,453 45,453 I
Loading xslF345X06/form4a-07302026_080752.xml…